Thursday, December 07, 2017 Citation for the primary publication for IND196 Leighl NB, Tsao MS, Liu G, Tu D, Ho C, Shepherd FA, Murray N, Goffin JR, Nicholas G, Sakashita S, Chen Z, Kim L, Powers J, Seymour L, Goss G, Bradbury PA. A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196. Oncotarget 8: 69651-62, 2017. http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path
